Cholinesterase Inhibition and Antioxidative Capacity of New Heteroaromatic Resveratrol Analogs: Synthesis and Physico-Chemical Properties
Published: June 24, 2024
The
targeted
compounds
in
this
research,
resveratrol
analogs
1–14
were
synthesized
as
mixtures
of
isomers
by
the
Wittig
reaction
using
heterocyclic
triphenylphosphonium
salts
and
various
benzaldehydes.
planned
those
possessing
trans-configuration
biologically
active
trans-resveratrol.
pure
obtained
repeated
column
chromatography
isolated
yields
depending
on
heteroaromatic
ring.
It
was
found
that
butyrylcholinesterase
(BChE)
more
sensitive
to
than
acetylcholinesterase
(AChE),
except
for
6,
methylated
thiophene
derivative
with
chlorine,
which
showed
equal
inhibition
toward
both
enzymes.
Compounds
5
8
achieved
highest
BChE
IC50
values
22.9
24.8
μM,
respectively.
same
AChE
BChE,
subunits
better
enzyme
unmethylated
ones.
Two
antioxidant
spectrophotometric
methods,
DPPH
CUPRAC,
applied
determine
potential
new
analogs.
Molecular
docking
these
conducted
visualize
ligand-active
site
complexes'
structure
identify
non-covalent
interactions
responsible
complex's
stability,
influence
inhibitory
potential.
As
ADME
properties
are
crucial
developing
drug
product
formulations,
they
have
also
been
addressed
work.
genotoxicity
is
evaluated
silico
studies
all
synthesized.
Language: Английский
Resveratrol-Based Carbamates as Selective Butyrylcholinesterase Inhibitors: Design, Synthesis, Computational Study and Biometal Complexation Capability
Mario Sviben,
No information about this author
Ilijana Odak,
No information about this author
Danijela Barić
No information about this author
et al.
Molecules,
Journal Year:
2025,
Volume and Issue:
30(2), P. 316 - 316
Published: Jan. 15, 2025
Considering
our
previous
experience
in
the
design
of
new
cholinesterase
inhibitors,
especially
resveratrol
analogs,
this
research,
basic
stilbene
skeleton
was
used
as
a
structural
unit
for
carbamates
designed
potentially
highly
selective
butyrylcholinesterase
(BChE)
inhibitors
with
excellent
absorption,
distribution,
metabolism,
excretion
and
toxicity
ADMET
properties.
The
inhibitory
activity
newly
prepared
1–13
tested
toward
enzymes
acetylcholinesterase
(AChE)
BChE.
In
group
compounds,
leading
were
1
7,
which
achieved
BChE
IC50
values
0.12
±
0.09
μM
0.38
0.01
μM,
respectively.
Both
much
more
active
than
standard
inhibitor
galantamine
against
Molecular
docking
most
promising
candidates,
compounds
revealed
that
stabilizing
interactions
between
site
residues
ligands
involve
π-stacking,
alkyl-π
interactions,
and,
when
carbamate
orientation
allows,
H-bond
formation.
MD
analysis
confirmed
stability
obtained
complexes.
Some
bioactive
resveratrol-based
displayed
complex-forming
capabilities
Fe3+
ions
metal
centers.
Spectrophotometric
investigation
indicated
they
coordinate
one
or
two
ions,
is
accordance
their
chemical
structure,
offering
binding
sites:
an
amine
carboxylic
moiety.
Based
on
silico,
experimental
computational
results
biological
present
work,
7
represent
potential
therapeutics
neurological
disorders.
Language: Английский
Recent Advances in Resveratrol Derivatives: Structural Modifications and Biological Activities
Molecules,
Journal Year:
2025,
Volume and Issue:
30(4), P. 958 - 958
Published: Feb. 19, 2025
Resveratrol,
a
naturally
occurring
phenolic
stilbene
molecule,
has
been
intensively
researched
for
its
anti-inflammatory,
anticancer,
antioxidant,
antibacterial,
and
neuroprotective
properties.
However,
due
to
limited
absorption
probable
hepatotoxicity,
it
is
difficult
employ
directly
as
medication,
limiting
therapeutic
applicability.
Over
the
last
five
years,
numerous
structural
changes
in
resveratrol
have
widely
studied,
resulting
considerable
improvements
pharmacological
activity
drug
availability.
This
work
reviews
biological
activities
structure-activity
relationships
(SARs)
of
derivatives,
with
goal
providing
useful
insights
discovery
new
derivatives.
Language: Английский
Experimental and DFT Approaches to Physico-Chemical Properties of Bioactive Resveratrol Analogues
Borislav Kovačević,
No information about this author
Ivana Šagud,
No information about this author
Katarina Marija Drmić
No information about this author
et al.
Molecules,
Journal Year:
2024,
Volume and Issue:
29(22), P. 5481 - 5481
Published: Nov. 20, 2024
Acetylcholinesterase
and
butyrylcholinesterase
are
two
related
enzymes
that
represent
pharmacologically
suitable
targets
in
neurodegenerative
disorders,
given
their
physiological
roles
the
body.
The
treatment
of
disorders
currently
includes
common
reversible
cholinesterase
inhibitors.
Resveratrol
analogues,
as
molecules
focus,
have
shown
very
strong
inhibition
potential
cholinesterases.
In
this
research,
experimental
DFT
approaches
for
p
Language: Английский